Grocery Prescription Program for Medicaid Adults With Hypertension or Type 2 Diabetes

Sponsor
Alison Gustafson (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06033664
Collaborator
Instacart Health (Other), Kentucky Association of Health Plans (Other)
60
1
1
5
11.9

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the effectiveness of a grocery prescription program in adults diagnosed with either Type 2 Diabetes Mellitus or Hypertension. Participants will enroll in Instacart Fresh Funds program. Once enrolled each week participants will select foods that are eligible in the Fresh Funds Program to be delivered to their home for 12 weeks. Participants will also participate in a survey at the beginning of the study and at the end of the study.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Fresh Funds
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Grocery Prescription Program for Medicaid Adults With Hypertension or Type 2 Diabetes
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Grocery Prescription Program

Participants will receive the Fresh Funds through Instacart

Behavioral: Fresh Funds
Participants will enroll in Instacart Fresh Funds program. Once enrolled participants will select foods that are eligible in the Fresh Funds to be delivered to their home each week for 12 weeks.
Other Names:
  • Grocery Prescription Program; Food As Medicine
  • Outcome Measures

    Primary Outcome Measures

    1. Number of participants with a percentage change in Hemoglobin A1C (HbgA1C) [baseline and post intervention, approximately 12 weeks]

      HbgA1C will be obtained baseline and post intervention by the healthcare provider from the medical chart.

    Secondary Outcome Measures

    1. Change in blood pressure [baseline and post intervention, approximately 12 weeks]

      Both systolic and diastolic blood pressure will be obtained baseline and post intervention by the healthcare provider from the medical chart.

    2. Change in food insecurity [baseline and post intervention, approximately 12 weeks]

      The USDA 6 item food insecurity screener will be used. The scale ranges from 0 to 6 with a higher score indicating greater food insecurity.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 64 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diagnosis of Type 2 Diabetes Mellitus, hemoglobin A1c = 7.0% and = 12.0% in last 12 months, or diagnosis of hypertension

    • Experiencing food insecurity as indicated by 2-item Hunger Vital Sign

    • English speaking

    • No plans to move from the area for at least 1 year

    • Willing and able to accept text messages

    • Free living to the extent that participant has control over dietary intake

    • Willing and able to provide written informed consent and participate in all study activities.

    Exclusion Criteria:
    • Participant in diabetes, nutrition, or weight research intervention in last 12 months

    • Another member of the household is already enrolled in this study

    • Considering bariatric surgery in the next year or prior bariatric surgery

    • Lack of safe, stable residence and ability to store meals

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Kentucky Lexington Kentucky United States 40506

    Sponsors and Collaborators

    • Alison Gustafson
    • Instacart Health
    • Kentucky Association of Health Plans

    Investigators

    • Principal Investigator: Alison Gustafson, PhD, University of Kentucky

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Alison Gustafson, Professor, University of Kentucky
    ClinicalTrials.gov Identifier:
    NCT06033664
    Other Study ID Numbers:
    • 88696
    First Posted:
    Sep 13, 2023
    Last Update Posted:
    Sep 13, 2023
    Last Verified:
    Sep 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Alison Gustafson, Professor, University of Kentucky
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 13, 2023